Scemblix(asciminib)是一款差异化产品，与市面TKI药物作用位点不同，通过抑制ABL肉豆蔻酰口袋发挥作用。 慢性髓性白血病-Scemblix ...

Doctors use molecular responses to monitor the effectiveness of CML treatment. A major molecular response is when the amount of the abnormal BCR–ABL gene in your blood and bone marrow is lowered to ...